Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31128Other human health activities94false2024-01-01falsefalsefalse 05329909 2024-01-01 2024-12-31 05329909 2023-01-01 2023-12-31 05329909 2024-12-31 05329909 2023-12-31 05329909 2023-01-01 05329909 1 2024-01-01 2024-12-31 05329909 1 2024-01-01 2024-12-31 05329909 d:Exceptional 2024-01-01 2024-12-31 05329909 d:Exceptional 2023-01-01 2023-12-31 05329909 e:Director1 2024-01-01 2024-12-31 05329909 e:Director2 2024-01-01 2024-12-31 05329909 e:Director3 2024-01-01 2024-12-31 05329909 e:Director3 2024-12-31 05329909 e:RegisteredOffice 2024-01-01 2024-12-31 05329909 d:MotorVehicles 2024-01-01 2024-12-31 05329909 d:MotorVehicles 2024-12-31 05329909 d:MotorVehicles 2023-12-31 05329909 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 05329909 d:MotorVehicles 1 2024-01-01 2024-12-31 05329909 d:FurnitureFittings 2024-01-01 2024-12-31 05329909 d:FurnitureFittings 2024-12-31 05329909 d:FurnitureFittings 2023-12-31 05329909 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 05329909 d:FurnitureFittings 1 2024-01-01 2024-12-31 05329909 d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 05329909 d:CurrentFinancialInstruments 2024-12-31 05329909 d:CurrentFinancialInstruments 2023-12-31 05329909 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 05329909 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 05329909 d:ShareCapital 2024-01-01 2024-12-31 05329909 d:ShareCapital 2024-12-31 05329909 d:ShareCapital 2023-01-01 2023-12-31 05329909 d:ShareCapital 2023-12-31 05329909 d:ShareCapital 2023-01-01 05329909 d:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 05329909 d:RetainedEarningsAccumulatedLosses 2024-12-31 05329909 d:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 05329909 d:RetainedEarningsAccumulatedLosses 2023-12-31 05329909 d:RetainedEarningsAccumulatedLosses 2023-01-01 05329909 d:AcceleratedTaxDepreciationDeferredTax 2024-12-31 05329909 d:AcceleratedTaxDepreciationDeferredTax 2023-12-31 05329909 e:OrdinaryShareClass1 2024-01-01 2024-12-31 05329909 e:OrdinaryShareClass1 2024-12-31 05329909 e:OrdinaryShareClass2 2024-01-01 2024-12-31 05329909 e:OrdinaryShareClass2 2024-12-31 05329909 e:FRS102 2024-01-01 2024-12-31 05329909 e:Audited 2024-01-01 2024-12-31 05329909 e:FullAccounts 2024-01-01 2024-12-31 05329909 e:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05329909 d:WithinOneYear 2024-12-31 05329909 d:WithinOneYear 2023-12-31 05329909 d:BetweenOneFiveYears 2024-12-31 05329909 d:BetweenOneFiveYears 2023-12-31 05329909 2 2024-01-01 2024-12-31 05329909 4 2024-01-01 2024-12-31 05329909 f:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 05329909









CARE 1ST LIMITED









DIRECTORS' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
CARE 1ST LIMITED
 
 
COMPANY INFORMATION


Directors
C K Donald 
J C Landucci-Harmey 




Registered number
05329909



Registered office
Crown House Stephenson Road
Severalls Industrial Park

Colchester

England

CO4 9QR






Independent auditors
Barnes Roffe Audit Limited
Chartered Accountants & Statutory Auditors

3 Brook Business Centre

Cowley Mill Road

Uxbridge

Middlesex

UB8 2FX





 
CARE 1ST LIMITED
 

CONTENTS



Page
Directors' report
1 - 2
Independent auditors' report
3 - 7
Statement of comprehensive income
8
Statement of financial position
9
Statement of changes in equity
10
Notes to the financial statements
11 - 19

 
CARE 1ST LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present their report and the financial statements for the year ended 31 December 2024.

Directors' responsibilities statement

The directors are responsible for preparing the Directors' report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Going concern

The Company has novated all care operations to other companies in the Cera Care Limited group and ceased trading on 27 April 2025. The directors are seeking to wind the company down with the intention of dissolving the company. Accordingly, the going concern basis of accounting is not appropriate and the financial statements have been prepared on a basis other than going concern. There are no adjustments required to the financial statements to draw them up on a break-up basis. Any liquidation costs in the future would be incurred by the parent company and not recharged to the Company, therefore no provisions have been made in the financial statements relating to the costing of winding down the business.

Directors

The directors who served during the year were:

C K Donald 
K M Cooper (resigned 5 March 2025)

J C Landucci-Harmey was appointed as a director on 20 February 2025.

Page 1

 
CARE 1ST LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditors are unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Auditors

After the year end, the directors decided to change the auditors of the Company and, as a result, Edmund Carr LLP will cease to hold office. Barnes Roffe Audit Limited have been appointed as auditors to fill the vacancy and will hold office until the conclusion of the next Annual General Meeting. A resolution to reappoint Barnes Roffe Audit Limited as the auditors of the Company will be proposed in the forthcoming Annual General Meeting.

Small companies note

In preparing this report, the directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.

This report was approved by the board on 14 July 2026 and signed on its behalf.
 





J C Landucci-Harmey
Director
Page 2

 
CARE 1ST LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF CARE 1ST LIMITED
 

Qualified Opinion


We were engaged to audit the financial statements of Care 1st Limited (“the Company”) for the year ended 31 December 2024, which comprise the Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).


We do not express an opinion on the accompanying financial statements of the Company. Because of the significance of the matters described in the basis for disclaimer of opinion section of our report, we have not been able to obtain sufficient appropriate audit evidence to provide a basis for an audit opinion on these financial statements.



Basis for disclaimer of opinion


During the course of the audit, there was a dispute between the Company’s directors which resulted in certain information and documentation not being made available to us. Consequently, we were unable to obtain supporting financial information for significant classes of transactions and balances within the financial statements.

In particular, management was unable to provide sufficient supporting records in respect of payroll and wages. As a result, we were unable to perform payroll testing and we were unable to confirm or verify by alternative means payroll costs and related balances included within the Statement of Comprehensive Income and Statement of Financial Position.

In addition, due to the lack of available information, we were unable to obtain sufficient appropriate audit evidence to support the completeness and accuracy of revenue.

Furthermore, the Company does not maintain formal documentation of its systems and internal controls, and the information available was insufficient to enable us to obtain an understanding of the design and implementation of controls relevant to the audit, as required by ISA (UK) 315. In addition, due to the limitations in available data and documentation, we were unable to obtain sufficient appropriate audit evidence to address the risk of management override of controls,.

Due to the material and pervasive nature of the matters described above, we were unable to determine whether any adjustments were necessary in respect of the Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity and the related notes to the financial statements.


Emphasis of matter - financial statements prepared on a basis other than going concern


We draw attention to note 2.2 in the financial statements, which indicates the accounts have not been prepared
on a going concern basis and that the directors do not believe any adjustment is required to the accounts in
respect of that decision as it would not materially alter a user's view of the financial statements. Our opinion is
not modified in respect of this matter.
 
Page 3

 
CARE 1ST LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF CARE 1ST LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

Notwithstanding our disclaimer of an opinion on the financial statementI in our opinion, based on the work undertaken in the course of the audit:


• the information given in the directors’ report for the financial year for which the financial statements are prepared is consistent with the financial statements; and 
• the directors’ report has been prepared in accordance with applicable legal requirements



Matters on which we are required to report by exception
 

Notwithstanding our disclaimer of an opinion on the financial statements, in the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit performed subject to the pervasive limitation described above, we have not identified material misstatements in the Directors' report.


Arising from the limitation of our work referred to above:
• we have not obtained all the information and explanations that we considered necessary for the purpose of  our audit; and
• we were unable to determine whether adequate accounting records have been kept.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit; or
the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemptions in preparing the Directors' report and from the requirement to prepare a Strategic report.


Page 4

 
CARE 1ST LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF CARE 1ST LIMITED (CONTINUED)


Responsibilities of directors
 

As explained more fully in the Directors' responsibilities statement set out on page 1, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.


Auditors' responsibilities for the audit of the financial statements
 

Our responsibility is to conduct an audit of the Company’s financial statements in accordance with International Standards on Auditing and to issue an auditor’s report. However, because of the matter described in the basis for disclaimer of opinion section of our report, we were not able to obtain sufficient appropriate audit evidence to provide a basis for an audit opinion on those financial statements.


We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements.

Other matters

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with law and regulations, was as follows:
 
The engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
We identified the laws and regulations applicable to the company through discussion with directors and other management, and from our commercial knowledge and experience of the relevant sector;
The specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, are as follows: 

i) Companies Act 2006.
ii) FRS 102.
iii) Tax legislation. 
iv) Employment legislation.
v) Health and safety
 
We assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and reviewing supporting evidence where applicable; and
Laws and regulations were communicated within the audit team at the planning meeting, and during the audit as any further laws and regulation were identified. The audit team remained alert to instances of non-compliance throughout the audit. 
 
Page 5

 
CARE 1ST LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF CARE 1ST LIMITED (CONTINUED)


We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur by: 
 
Making enquiries of management as to where they consider there was susceptibility to fraud and their knowledge of actual suspected and alleged fraud;
Considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations;
Reviewing the financial statements and testing the disclosures against supporting documentation;
Performing analytical procedures to identify any unusual or unexpected trends or anomalies;
Inspecting and testing journal entries to identify unusual or unexpected transactions;
Assessing whether judgement and assumptions made in determining significant accounting estimates, were indicative of management bias; and
Investigating the rationale behind significant transactions, or transactions that are unusual or outside the company's usual course of business.
 
The areas that we identified as being susceptible to misstatement through fraud were:
 
Management bias in the estimates and judgements made; 
Management override of controls; and
Posting of unusual journals or transactions.
 
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation.  This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.


However, because of the matters described in the Basis for Disclaimer of Opinion section, we were unable to perform all of the procedures that we would ordinarily undertake in response to assessed risks of material misstatement due to fraud, including procedures relating to management override of controls. Accordingly, we were unable to obtain sufficient appropriate audit evidence as to whether material misstatements arising from fraud or error may exist within the financial statements.


Page 6

 
CARE 1ST LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF CARE 1ST LIMITED (CONTINUED)


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





Mark Hancock (Senior statutory auditor)
for and on behalf of
Barnes Roffe Audit Limited
Chartered Accountants & Statutory Auditors
3 Brook Business Centre
Cowley Mill Road
Middlesex
UB8 2FX

14 July 2026
Page 7

 
CARE 1ST LIMITED
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

Year ended 31 December 2024
11 months period ended 31 December 2023
£
£

  

Turnover
  
5,913,709
4,939,838

Cost of sales
  
(3,710,214)
(2,888,187)

Gross profit
  
2,203,495
2,051,651

Administrative expenses
  
(1,038,212)
(944,182)

Exceptional expenses
  
-
(1,725,000)

Other operating income
  
-
61,041

Operating profit/(loss)
  
1,165,283
(556,490)

Interest receivable and similar income
  
23,910
4,152

Interest payable and similar expenses
  
-
(3,433)

Profit/(loss) before tax
  
1,189,193
(555,771)

Tax on profit/(loss)
  
-
(23,047)

Profit/(loss) for the financial year/period
  
1,189,193
(578,818)

Total comprehensive income for the year/period
  
1,189,193
(578,818)

The notes on pages 11 to 19 form part of these financial statements.
Page 8

 
CARE 1ST LIMITED
REGISTERED NUMBER: 05329909

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024


2024

2023
Note
£
£
£
£

Fixed assets
  

Tangible assets
 6 
-
44,000

  
-
44,000

Current assets
  

Fixed assets held for sale
     7
32,314
-

Debtors: amounts falling due within one year
 8 
963,372
946,000

Cash at bank and in hand
 9 
2,125,013
1,057,447

  
3,120,699
2,003,447

Creditors: amounts falling due within one year
 10 
(370,456)
(486,397)

Net current assets
  
 
 
2,750,243
 
 
1,517,050

Total assets less current liabilities
  
2,750,243
1,561,050

  

Net assets
  
2,750,243
1,561,050


Capital and reserves
  

Called up share capital 
 12 
50
50

Profit and loss account
  
2,750,193
1,561,000

  
2,750,243
1,561,050


The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 14 July 2026.




J C Landucci-Harmey
Director

The notes on pages 11 to 19 form part of these financial statements.
Page 9

 
CARE 1ST LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024


Called up share capital
Profit and loss account
Total equity

£
£
£


At 31 January 2023 (as restated)
50
2,139,818
2,139,868


Comprehensive income for the year

Loss for the year
-
(578,818)
(578,818)
Total comprehensive income for the year
-
(578,818)
(578,818)



At 31 December 2023
50
1,561,000
1,561,050


Comprehensive income for the year

Profit for the year
-
1,189,193
1,189,193
Total comprehensive income for the year
-
1,189,193
1,189,193


At 31 December 2024
50
2,750,193
2,750,243


The notes on pages 11 to 19 form part of these financial statements.
Page 10

 
CARE 1ST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Care 1st Limited is a company limited by shares, incorporated in England and Wales. The address of the registered office is Crown House Stephenson Road, Severalls Industrial Park, Colchester, England, CO4 9QR.

The company previously specialised in the provision of domiciliary care services to the elderly, but has ceased trading from 27 April 2025, with its trading activities passed to another group company and is therefore now dormant.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

  
2.2

Going concern

The Company has novated all care operations to other companies in the Cera Care Limited group and ceased trading on 27 April 2025. The directors are seeking to wind the company down with the intention of dissolving the company. Accordingly, the going concern basis of accounting is not appropriate and the financial statements have been prepared on a basis other than going concern. There are no adjustments required to the financial statements to draw them up on a break-up basis. Any liquidation costs in the future would be incurred by the parent company and not recharged to the Company, therefore no provisions have been made in the financial statements relating to the costing of winding down the business.

 
2.3

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Cera Care Limited as at 31 December 2024 and these financial statements may be obtained from Crown House, Stephenson Road, Severalls Industrial Park, Colchester, CO4 9QR.

Page 11

 
CARE 1ST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of comprehensive income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

 
2.5

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.6

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to the Statement of comprehensive income on a straight-line basis over the lease term.

Page 12

 
CARE 1ST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.7

Interest income

Interest income is recognised in the Statement of comprehensive income using the effective interest method.

 
2.8

Finance costs

Finance costs are charged to the Statement of comprehensive income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.9

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in the Statement of comprehensive income when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.10

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in the Statement of comprehensive income except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


Page 13

 
CARE 1ST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.11

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.

 
2.12

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Motor vehicles
-
20%
straight line
Fixtures, fittings and equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of comprehensive income.

 
2.13

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.14

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.15

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 14

 
CARE 1ST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.16

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to the Statement of comprehensive income.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2024
        2023
            No.
            No.







Employees
94
128


4.


Directors' remuneration

Year ended 31 December 2024
11 months period ended 31 December 2023
£
£

Directors' emoluments
4,160
-

4,160
-



5.


Exceptional items

Year ended 31 December 2024
11 months period ended 31 December 2023
£
£


Exceptional items
-
1,725,000

-
1,725,000

Page 15

 
CARE 1ST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

6.


Tangible fixed assets


Motor vehicles
Fixtures, fittings and equipment
Total

£
£
£





At 1 January 2024
23,318
95,357
118,675


Additions
-
3,292
3,292


Disposals
(1,929)
-
(1,929)


Reclassified to held for sale
(21,389)
(98,649)
(120,038)



At 31 December 2024

-
-
-





At 1 January 2024
10,850
63,825
74,675


Charge for the period
6,300
8,410
14,710


Disposals
(1,661)
-
(1,661)


Reclassified to held for sale
(15,489)
(72,235)
(87,724)



At 31 December 2024

-
-
-



Net book value



At 31 December 2024
-
-
-



At 31 December 2023
12,468
31,532
44,000


7.


Fixed Assets held for sale

2024
2023
£
£



Fixed assets held for sale
32,314
-

32,314
-

Page 16

 
CARE 1ST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

8.


Debtors

2024
2023
£
£


Trade debtors
731,740
740,115

Other debtors
113,595
69,323

Prepayments and accrued income
111,850
130,562

Deferred taxation
6,187
6,000

963,372
946,000



9.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
2,125,013
1,057,447

2,125,013
1,057,447



10.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
25,161
42,842

Amounts owed to group undertakings
51,619
-

Corporation tax
-
187,000

Other taxation and social security
67,134
56,596

Other creditors
22,898
16,671

Accruals and deferred income
203,644
183,288

370,456
486,397


Page 17

 
CARE 1ST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

11.


Deferred taxation




2024


£






At beginning of year
6,000


Charged to profit or loss
187



At end of year
6,187

The deferred tax asset is made up as follows:

2024
2023
£
£


Accelerated capital allowances
6,187
6,000

6,187
6,000


12.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



45 Ordinary A shares of £1 each
45
45
5 Ordinary B shares of £1 each
5
5

50

50

All ordinary shares have full rights in the Company and rank pari passu in all respects but each class of share constitute as a separate class of share.



13.


Pension commitments

The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £74,201 (11 months period ended 31 December 2023 - £55,335). At the reporting date £13,573 (31 December 2023 - £Nil) was payable by the company to the pension scheme.

Page 18

 
CARE 1ST LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

14.


Commitments under operating leases

At 31 December 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Not later than 1 year
36,000
36,000

Later than 1 year and not later than 5 years
61,667
97,667

97,667
133,667


15.Guarantees

On 15 September 2023, the Company entered into a debenture in favour of Glas Trust Corporation Limited. The debenture includes a fixed charge, floating charge and negative pledge covering all current and future property and undertaking of the Company. The guarantee was satisfied on 9 January 2025. 


16.


Related party transactions

The company has taken advantage of the exemption allowed by Financial Reporting Standard 102 not to
disclose any transactions with other wholly owned members of the group.


17.


Post balance sheet events

The Company has novated all care operations to other companies in the Cera Care Limited group and ceased trading on 27 April 2025. The directors are seeking to wind the company down with the intention of dissolving the company.


18.


Ultimate controlling party

The immediate parent company undertaking is Cera Care Operations Holdings Limited, a company incorporated in England and Wales. The ultimate parent company is Cera Care Limited in which the Company’s financial statements are consolidated, and which can be obtained from Companies House. The registered office address of Cera Care Limited and Cera Care Operations Holdings Limited is Labs Hawley Lock Offices 029, 032, 033 & 34, 1 Water Lane, Camden, London, England, NW1 8NZ.

 
Page 19